Drug Pipeline

Pertuzumab Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07196774 A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in… Early-stage or Locally Advanced HER2-positive Breast Cancer Recruiting
Phase 2
NCT06348134 Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+… Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Recruiting
Phase 1/2
NCT05150691 A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors HER2-positive Advanced Solid Tumor Recruiting
Sponsors Running Pertuzumab Injection Trials
DualityBio Inc. (1) University of Chicago (1) Jiangsu HengRui Medicine Co., Ltd. (1)
Disease Areas
Breast Cancer (2) HER2-Positive Breast Cancer (2)
Get alerts when Pertuzumab Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free